Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CYDY - Regeneron's Positive Dupixent Data And Other News: The Good Bad And Ugly Of Biopharma

CYDY - Regeneron's Positive Dupixent Data And Other News: The Good Bad And Ugly Of Biopharma

CytoDyn Inc
  • Regeneron reports positive data for Dupixent pivotal trial.
  • CytoDyn reports encouraging data for Leronlimab in stroke patients.
  • Turning Point Therapeutics announces positive results from TPX-0022 trial.

For further details see:

Regeneron's Positive Dupixent Data, And Other News: The Good, Bad And Ugly Of Biopharma
Stock Information
Company Name: CytoDyn Inc
Stock Symbol: CYDY
Market: OTC
Website: cytodyn.com
Menu
CYDY CYDY Quote CYDY Short CYDY News CYDY Articles CYDY Message Board
Get CYDY Alerts

News, Short Squeeze, Breakout and More Instantly...